Drug Treatment of Patients with Decompensated Heart Failure

ISSN： 1175-3277

Source： American Journal of Cardiovascular Drugs, Vol.1, Iss.2, 2001-01, pp. : 119-125

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Nesiritide: A Promising New Drug for the Treatment of Decompensated Heart Failure

Heart Drug, Vol. 2, Iss. 1, 2002-04 ,pp. : 39-46

Karger

Access to resources Recommend Favorite

Levosimendan: A New Inodilatory Drug for the Treatment of Decompensated Heart Failure

Current Pharmaceutical Design, Vol. 11, Iss. 4, 2005-02 ,pp. : 435-455

Bentham Science Publishers

Access to resources Recommend Favorite

An update on nesiritide for treatment of decompensated heart failure

By Hobbs R.E. Mills R.M. Young J.B.

Expert Opinion on Investigational Drugs, Vol. 10, Iss. 5, 2001-05 ,pp. : 935-942

Informa Healthcare

Access to resources Recommend Favorite

Benefit-Risk Assessment of Nesiritide in the Treatment of Acute Decompensated Heart Failure

By Yancy Clyde W.

Drug Safety, Vol. 30, Iss. 9, 2007-01 ,pp. : 765-781

Adis International

Access to resources Recommend Favorite

Levosimendan Use Reduces Matrix Metalloproteinase-2 in Patients with Decompensated Heart Failure

By Tziakas Dimitrios Chalikias Georgios Hatzinikolaou Helen Stakos Dimitrios Papanas Nikolaos Tentes Ioannis Kortsaris Alexandros Maltezos Efstratios Hatseras Dimitrios Kaski Juan

Cardiovascular Drugs and Therapy, Vol. 19, Iss. 6, 2005-12 ,pp. : 399-402

Springer Publishing Company

Access to resources Recommend Favorite